Search research articles
Contact Us
Filters
Showing results (41-50 of 46) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 46 results.
Acta Neuropathologica
|
July 11, 2014
Whole exome sequencing reveals that the majority of schwannomatosis cases remain unexplained after excluding SMARCB1 and LZTR1 germline variants
Sonja Hutter, Rosario M Piro, David E Reuss, et al.
Neurology
|
August 17, 2016
Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis
Shivani Ahlawat, Laura M Fayad, Muhammad Shayan Khan, et al.
Neuro-Oncology
|
March 3, 2023
Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities
Catena Kresbach, Matthias Dottermusch, Alicia Eckhardt, et al.
Lancet (London, England)
|
June 5, 2025
Efficacy and safety of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas (KOMET): a multicentre, international, randomised, placebo-controlled, parallel, double-blind, phase 3 study
Alice P Chen, Geraldine O'Sullivan Coyne, Pamela L Wolters, et al.
American Journal of Medical Genetics. Part A
|
November 14, 2014
Recent developments in neurofibromatoses and RASopathies: management, diagnosis and current and future therapeutic avenues
Katherine A Rauen, Susan M Huson, Emma Burkitt-Wright, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 1, 2015
Critical role of platelet glycoprotein ibα in arterial remodeling
Sue Chandraratne, Marie-Luise von Bruehl, Judith-Irina Pagel, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 46) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 46 results.
Acta Neuropathologica
|
July 11, 2014
Whole exome sequencing reveals that the majority of schwannomatosis cases remain unexplained after excluding SMARCB1 and LZTR1 germline variants
Sonja Hutter, Rosario M Piro, David E Reuss, et al.
Neurology
|
August 17, 2016
Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis
Shivani Ahlawat, Laura M Fayad, Muhammad Shayan Khan, et al.
Neuro-Oncology
|
March 3, 2023
Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities
Catena Kresbach, Matthias Dottermusch, Alicia Eckhardt, et al.
Lancet (London, England)
|
June 5, 2025
Efficacy and safety of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas (KOMET): a multicentre, international, randomised, placebo-controlled, parallel, double-blind, phase 3 study
Alice P Chen, Geraldine O'Sullivan Coyne, Pamela L Wolters, et al.
American Journal of Medical Genetics. Part A
|
November 14, 2014
Recent developments in neurofibromatoses and RASopathies: management, diagnosis and current and future therapeutic avenues
Katherine A Rauen, Susan M Huson, Emma Burkitt-Wright, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 1, 2015
Critical role of platelet glycoprotein ibα in arterial remodeling
Sue Chandraratne, Marie-Luise von Bruehl, Judith-Irina Pagel, et al.
Page
of 5